A parallel increase in systemic plasma levels of neuropeptide Y (NPY)-like immunoreactivity
(LI) and noradrenaline (NA) was found during thoracotomy and surgery involving …

The local clearance of neuropeptide Y (NPY) and whether NPY influences splanchnic and
renal metabolism in man have not been investigated previously. The influence of NPY on …

The myocardial release of neuropeptide Y‐like immunoreactivity (NPY‐LI) and
noradrenaline (NA) during exercise with and without arterial hypoxia was measured in 18 …

Although neuropeptide Y (NPY) is not a potent vasoconstrictor in many vascular beds,
nanomolar concentrations of this peptide can potentiate the response of isolated blood …

Neuropeptide Y (NPY) is widely distributed in central and peripheral neurons. In sympathetic
postganglionic neurons, NPY coexists with noradrenaline. NPY and its structural relative …

The importance of impulse pattern and stimulation frequency for the release of
noradrenaline (NA) and the coexisting peptide neuropeptide Y (NPY) in relation to …

Antecubital venous plasma neuropeptide Y-like immunoreactivity (NPY-LI) and
catecholamines were analyzed in six healthy, volunteers performing a graded bicycle …

The effect of neuropeptide Y (NPY) on fractional tritium-noradrenaline (3H-NA) release and
contractile activity was studied in the isolated portal vein of SHR and WKY rats. NPY (5 X 10 …

1 The contractile effect of neuropeptide Y (NPY) was tested on isolated segments of basilar
artery, central ear artery, gastro‐epiploic artery and vein, and femoral artery and vein from …

Neuropeptide Y (NPY) coexists with noradrenaline in postganglionic sympathetic neurons.
In order to test the hypothesis that NPY may be released along with catecholamines by …